Login
Login     |     Register     |     Recover Username/Password

General Investing

Ascent Solar Technologies (ASTI) Carves Downstream Niche with CIGS Solar Technology

February 20, 2013

Ascent Solar Technologies (ASTI) carves a niche away from the traditional rooftop solar farm and applies its flexible, light-weight CIGS technology to go downstream directly to customers with its Enerplex brand and bypass its competitors to move up the value chain, says Victor Lee, CEO of the company.

“In terms of the power-to-weight ratio, Ascent is clearly a leader. If you measure by the surface area on a per-square-meter basis, our modules produce at least 85 watts, which is among the highest in the thin-film space, except that it is not comparable to SunPower (SPWR) or First Solar (FSLR),” Lee said. “If you combine the two metrics, that put us in a really good comfortable competitive position.”

Lee says CIGS technology, besides being lightweight and flexible, has room for growth as far as technology efficiency. He also highlights the capacity of these modules to absorb sunlight on cloudy days, a feature that becomes especially important in the Northern hemisphere, as it almost doubles the length of time the panels can produce electricity.

“That makes a lot of difference with CIGS technology, and we are talking about how our modules can function even up to five to six hours. And for some countries, like the tropical countries of Southeast Asia, that makes a lot of difference. If you put it on a portable solar charging device like this, you can take it everywhere you go. You still capture the sunlight, and you still can power your cell phone. That makes our products very, very appealing,” Lee said.

FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now